In silico identification of prolyl hydroxylase inhibitor by per‐residue energy decomposition‐based pharmacophore approach
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In silico identification of prolyl hydroxylase inhibitor by per‐residue energy decomposition‐based pharmacophore approach
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-04-19
DOI
10.1002/jcb.29933
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In silico identification of hydantoin derivatives: a novel natural prolyl hydroxylase inhibitor
- (2020) Mahesh Kumar Teli et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience
- (2019) Neil S. Sanghani et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases
- (2018) Amit A. Joharapurkar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular Insights into the Interaction of RONS and Thieno[3,2-c]pyran Analogs with SIRT6/COX-2: A Molecular Dynamics Study
- (2018) Dharmendra K. Yadav et al. Scientific Reports
- The Identification of potential human rhinovirus inhibitors: exploring the binding landscape of HRV-3C protease through PRED pharmacophore screening
- (2017) Ndumiso M Buthelezi et al. Future Virology
- β-N-oxalyl-L-α, β- diaminopropionic acid induces HRE expression by inhibiting HIF-prolyl hydroxylase-2 in normoxic conditions
- (2016) Ravi Kumar Eslavath et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease
- (2016) Pablo E. Pergola et al. KIDNEY INTERNATIONAL
- Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
- (2016) Rasheduzzaman Chowdhury et al. Nature Communications
- Computational Repositioning and Experimental Validation of Approved Drugs for HIF-Prolyl Hydroxylase Inhibition
- (2013) Mahesh Kumar Teli et al. Journal of Chemical Information and Modeling
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
- (2013) G. Madhavi Sastry et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Inhibition of Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Oxygen Sensors: Tricking the Body into Mounting Orchestrated Survival and Repair Responses
- (2013) Michael H. Rabinowitz JOURNAL OF MEDICINAL CHEMISTRY
- Computational identification of novel histone deacetylase inhibitors by docking based QSAR
- (2012) Syam B. Nair et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Identification of novel potential HIF-prolyl hydroxylase inhibitors by in silico screening
- (2011) Mahesh Kumar Teli et al. MOLECULAR DIVERSITY
- Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia
- (2010) Lin Yan et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues
- (2010) Mark D. Rosen et al. ACS Medicinal Chemistry Letters
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started